DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Pharmaceuticals & Biotech
Updated 1m ago
000423 logo

Dong-E-E-Jiao Co., Ltd.SZSE:000423 Stock Report

Market Cap CN¥29.4b
Updated 1m ago
Share Price
n/a
1Y-3.4%
7D-1.6%
1D-0.8%
Portfolio Value
​
View

Dong-E-E-Jiao Co., Ltd.

SZSE:000423 Stock Report

Market Cap: CN¥29.4b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Dong-E-E-Jiao (000423) Stock Overview

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally. More details

000423 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth1/6
Past Performance3/6
Financial Health5/6
Dividends3/6

Rewards

Trading at 64.1% below our estimate of its fair value

Earnings are forecast to grow 12.68% per year

Earnings grew by 9.3% over the past year

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 56.9%

Risk Analysis

High level of non-cash earnings

Dividend of 5.87% is not well covered by earnings or free cash flows


000423 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW444,721 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
444,721 investors already sharing narratives
CN¥
Current Price
CN¥46.1122.9% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-732m12b2016201920222025202620282031Revenue CN¥11.7bEarnings CN¥3.1b
Advanced
View all narratives

Dong-E-E-Jiao Co., Ltd. Competitors

Shenzhen Salubris Pharmaceuticals

Symbol: SZSE:002294
Market cap: CN¥33.5b

China Resources Sanjiu Medical & Pharmaceutical

Symbol: SZSE:000999
Market cap: CN¥40.4b

Humanwell Healthcare (Group)Ltd

Symbol: SHSE:600079
Market cap: CN¥30.3b

Betta Pharmaceuticals

Symbol: SZSE:300558
Market cap: CN¥19.7b

Price History & Performance

Summary of share price highs, lows and changes for Dong-E-E-Jiao
Historical stock prices
Current Share PriceCN¥46.11
52 Week HighCN¥58.36
52 Week LowCN¥42.88
Beta0.011
1 Month Change-11.19%
3 Month Change-2.56%
1 Year Change-3.35%
3 Year Change-5.63%
5 Year Change41.57%
Change since IPO2,781.50%

Recent News & Updates

Recent updates

Analysis Article • Jan 31

Little Excitement Around Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) Earnings

Dong-E-E-Jiao Co.,Ltd.'s ( SZSE:000423 ) price-to-earnings (or "P/E") ratio of 25.7x might make it look like a buy...
Analysis Article • Nov 06

We Think Dong-E-E-JiaoLtd's (SZSE:000423) Robust Earnings Are Conservative

Dong-E-E-Jiao Co.,Ltd. ( SZSE:000423 ) just reported healthy earnings but the stock price didn't move much. Our...
Analysis Article • Oct 14

Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) Shares Climb 34% But Its Business Is Yet to Catch Up

Dong-E-E-Jiao Co.,Ltd. ( SZSE:000423 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Sep 13

Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Shares Could Be 37% Below Their Intrinsic Value Estimate

Key Insights Using the 2 Stage Free Cash Flow to Equity, Dong-E-E-JiaoLtd fair value estimate is CN¥72.15 Current share...
Analysis Article • May 21

Are Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Investors Paying Above The Intrinsic Value?

Key Insights Dong-E-E-JiaoLtd's estimated fair value is CN¥55.28 based on 2 Stage Free Cash Flow to Equity...
Analysis Article • Mar 31

Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest

Even though Dong-E-E-Jiao Co.,Ltd.'s ( SZSE:000423 ) recent earnings release was robust, the market didn't seem to...
Analysis Article • Mar 25

Analysts Are Updating Their Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Estimates After Its Annual Results

Shareholders might have noticed that Dong-E-E-Jiao Co.,Ltd. ( SZSE:000423 ) filed its annual result this time last...
Analysis Article • Mar 21

Some Shareholders Feeling Restless Over Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) P/E Ratio

With a price-to-earnings (or "P/E") ratio of 36.2x Dong-E-E-Jiao Co.,Ltd. ( SZSE:000423 ) may be sending bearish...

Shareholder Returns

000423CN PharmaceuticalsCN Market
7D-1.6%-2.6%-2.6%
1Y-3.4%-23.2%-0.9%

Return vs Industry: 000423 exceeded the CN Pharmaceuticals industry which returned -23.2% over the past year.

Return vs Market: 000423 underperformed the CN Market which returned -0.9% over the past year.

Price Volatility

Is 000423's price volatile compared to industry and market?
000423 volatility
000423 Average Weekly Movement4.1%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement7.0%
10% most volatile stocks in CN Market12.0%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 000423 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 000423's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19524,345Jinni Sunwww.dongeejiao.com

Dong-E-E-Jiao Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally. The company offers donkey-hide gelatin products, including medicinal herb, oral liquid, cake, fish maw, powder, minced meat, bird's nest products, dates, red date black sesame and juice soft candy, and essence drink, as well as related traditional Chinese medicines, health food, and food products under various brand names. It is also involved in the wholesale and retail of pre-packaged food; livestock breeding; and import and export businesses.

Dong-E-E-Jiao Co., Ltd. Fundamentals Summary

How do Dong-E-E-Jiao's earnings and revenue compare to its market cap?
000423 fundamental statistics
Market capCN¥29.43b
Earnings (TTM)CN¥1.78b
Revenue (TTM)CN¥6.80b
16.5x
P/E Ratio
4.3x
P/S Ratio

Is 000423 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000423 income statement (TTM)
RevenueCN¥6.80b
Cost of RevenueCN¥1.76b
Gross ProfitCN¥5.04b
Other ExpensesCN¥3.26b
EarningsCN¥1.78b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)2.80
Gross Margin74.11%
Net Profit Margin26.23%
Debt/Equity Ratio0.1%

How did 000423 perform over the long term?

See historical performance and comparison

Dividends

5.9%
Current Dividend Yield
100%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/15 16:38
End of Day Share Price 2026/09/15 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dong-E-E-Jiao Co., Ltd. is covered by 25 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jessica LiBofA Global Research
Yanyin ZhuChina International Capital Corporation Limited
Bing ZhaoChina Renaissance Securities

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide